Skip to main content
. 2022 Mar 5;27(4):323–327. doi: 10.1093/oncolo/oyab081

Table 4.

Mean ESAS items (mean, SD) and methadone dose (mg, mean, SD) in group H.

T0 T7 T14 T30 T60 P intragroup
n = 20 n = 18 n = 16 n = 15 n = 13
Pain 6.7 (2.1) 3.6 (1.6) 3.4 (2.0) 3.7 (1.9) 2.5 (1.7) <.0005
Weakness 5.8 (3.0) 4.4 (2.2) 4.6 (3.0) 4.5 (2.2) 4.2 (2.6) <.0005
Nausea 1.6 (2.2) 0.3 (0.8) 1.5 (2.8) 0.5 (1.6) 1.6 (3.0) .011
Depression 3.8 (2.9) 2.1 (2.2) 2.2 (2.0) 2.0 (1.5) 3.7 (2.2) <.0005
Anxiety 3.2 (3.6) 2.8 (2.4) 2.0 (2.2) 3.1 (2.6) 3.0 (2.5) <.0005
Drowsiness 3.6 (3.1) 3.1 (2.7) 3.6 (3.2) 2.7 (2.8) 2.9 (2.5) .001
Dyspnea 1.3 (2.4) 0.7 (1.4) 1.1 (1.7) 0.8 (1.4) 0.8 (1.2) .04
Insomnia 4.0 (3.0) 1.1 (1.6) 1.2 (1.7) 1.7 (1.9) 0.9 (1.4) <.0005
Poor appetite 3.6 (3.0) 1.6 (1.9) 2.2 (3.3) 0.7 (1.9) 2.2 (3.6) <.0005
Poor well-being 4.7 (3.5) 2.1 (2.4) 2.8 (2.9) 2.7 (1.4) 2.5 (2.9) .001
Total ESAS 38.4 (19.6) 21.7 (10.8) 25.2 (17.9) 22.5 (11.5) 25.2 (19.6) <.0005
Methadone dose 9 10 (3.2) 11.2 (7.9) 11.7 (8.3) 10.5 (4.7) .281